Alsufyani Hadeel A, Daly Craig, Docherty James R
Department of Physiology, King Abdulaziz University, Jeddah, Saudi Arabia.
School of Life Sciences, University of Glasgow, Glasgow, UK.
Basic Clin Pharmacol Toxicol. 2021 Dec;129(6):416-426. doi: 10.1111/bcpt.13639. Epub 2021 Sep 25.
We have investigated the interaction of α - and α -adrenoceptor subtypes in producing isometric contractions to NA in mouse whole spleen. The α -adrenoceptor antagonist prazosin (10 M) or the α -adrenoceptor antagonist yohimbine (10 M) alone produced only small shifts in NA potency in wild type (WT) mice, but the combination produced a large shift in NA potency. In spleen from α -KO mice, the effects of prazosin and the combination of prazosin and yohimbine were similar to their effects in WT mice. Hence, in α -KO mice, in which the only α -adrenoceptor present is the α -adrenoceptor, prazosin still antagonized contractions to NA. The α -adrenoceptor antagonist RS100329 (3 × 10 M) produced significant shifts in the effects of higher concentrations of NA (EC and EC levels) and the α -adrenoceptor antagonist BMY7378 (3 × 10 M) produced significant shifts in the effects of lower concentrations of NA (EC and EC levels). The effects of BMY7378 and RS00329 demonstrate α -adrenoceptor and α -adrenoceptor components and suggest that the α -adrenoceptor interacts with an α -adrenoceptor, and to a lesser extent an α -adrenoceptor, at low, and an α -adrenoceptor at high, NA concentrations. This study demonstrates the complex interaction between α - and α -adrenoceptor subtypes in producing contractions of mouse spleen and may have general implications for α-adrenoceptor mediated control of smooth muscle.
我们研究了α-和α-肾上腺素能受体亚型在小鼠全脾对去甲肾上腺素(NA)产生等长收缩过程中的相互作用。α-肾上腺素能受体拮抗剂哌唑嗪(10⁻⁶M)或α-肾上腺素能受体拮抗剂育亨宾(10⁻⁶M)单独使用时,在野生型(WT)小鼠中仅使NA效力产生小的变化,但两者联合使用则使NA效力产生大的变化。在α-KO小鼠的脾脏中,哌唑嗪以及哌唑嗪与育亨宾联合使用的效果与它们在WT小鼠中的效果相似。因此,在仅存在α-肾上腺素能受体的α-KO小鼠中,哌唑嗪仍能拮抗对NA的收缩反应。α-肾上腺素能受体拮抗剂RS100329(3×10⁻⁶M)使较高浓度NA(EC₅₀和EC₉₀水平)的作用产生显著变化,而α-肾上腺素能受体拮抗剂BMY7378(3×10⁻⁶M)使较低浓度NA(EC₁₀和EC₃₀水平)的作用产生显著变化。BMY7378和RS00329的作用表明存在α-肾上腺素能受体和α-肾上腺素能受体成分,并提示在低NA浓度时α-肾上腺素能受体与α-肾上腺素能受体相互作用,且在较小程度上与α-肾上腺素能受体相互作用,在高NA浓度时与α-肾上腺素能受体相互作用。本研究证明了α-和α-肾上腺素能受体亚型在小鼠脾脏收缩过程中的复杂相互作用,可能对α-肾上腺素能受体介导的平滑肌控制具有普遍意义。